Cold ischemia does not interfere with tolerance induction

Transplantation

Volumn 87, Issue 8, 2009, Pages 1116-1124

  Reutzel Selke, Anja ^a   Hartmann, Jan ^a   Brandenburg, Paul ^a   Jurisch, Anke ^a,b   Francuski, Maja ^a   Ulrich, Frank ^a   Kotsch, Katja ^a   Pascher, Andreas ^a   Neuhaus, Peter ^a   Tullius, Stefan G ^b   Pratschke, Johann ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adoptive cell transfer; Anti CD4 mAb; Cold ischemic time; Rat renal transplantation; Tolerance induction

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY RIB 5 2; UNCLASSIFIED DRUG; ABATACEPT; ANTIBODY CONJUGATE; CD4 ANTIGEN; CREATININE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; DARK AGOUTI RAT; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; KIDNEY FUNCTION; LEWIS RAT; LYMPHOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; T LYMPHOCYTE; ALLOTRANSPLANTATION; ANIMAL; BIOSYNTHESIS; BLOOD; FLOW CYTOMETRY; GRAFT SURVIVAL; IMMUNOLOGY; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; METHODOLOGY; PHYSIOLOGY; PROTEINURIA; RAT STRAIN; REOPERATION; TRANSPLANTATION TOLERANCE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD4; COLD ISCHEMIA; CREATININE; FLOW CYTOMETRY; GRAFT SURVIVAL; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; PROTEINURIA; RATS; RATS, INBRED LEW; RATS, INBRED STRAINS; REOPERATION; T-LYMPHOCYTES; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 65549168612     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31819dfb29     Document Type: Article

References (51)

1. Onodera K, Chandraker A, Volk HD, et al. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2. Transplantation 1999; 68: 288.
2. Li Y, Li XC, Zheng XX, et al. Blocking signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 1999; 5: 1298.
3. Sayegh MH, Turka LA. T cell co-stimulatory pathways: Promising novel targets for immunosuppression and tolerance induction. J Am Soc Nephrol 1995; 6: 1143.
4. Graser E, Risch K, Linsley PS, et al. Synergism of CTLA-4Ig and anti- CD4 mAb treatment in a rat kidney transplant model. Transplant Proc 1997; 29: 1307.
5. Siegling A, Lehmann M, Riedel H, et al. A nondepleting anti-rat CD4 monoclonal antibody which suppresses T helper 1-like but not T helper 2-like intragraft lymphokine secretion induces long-term survival of renal allografts. Transplantation 1994; 57: 464.
6. Sawitzki B, Kieselbach B, Fisser M, et al. IFN-gamma regulation in anti-CD4 antibody-induced T cell unresponsiveness. J Am Soc Nephrol 2004; 15: 695.
7. Sawitzki B, Lehmann M, Ritter T, et al. Regulatory tolerance-mediating T cells in transplantation tolerance. Transplant Proc 2001; 33: 2092.
8. Waldmann H, Adams E, Fairchild P, et al. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol Rev 2006; 212: 301.
9. Qin S, Cobbold SP, Pope H, et al. Infectious transplantation tolerance. Science 1993; 259: 974.
10. Akl A, Luo S, Wood KJ. Induction of transplantation tolerance-the potential of regulatory T cells. Transpl Immunol 2005; 14: 225.
11. Waldmann H, Cobbold SP. Regulating the immune response to transplants. A role for CD4- regulatory cells? Immunity 2001; 14: 399.
12. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 1641.
13. Clarkson MR, Sayegh MH. T-cell costimulatory pathways in allograft rejection and tolerance. Transplantation 2005; 80: 555.
14. Sayegh MH, Zheng XG, Magee C, et al. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients. Transplantation 1997; 64: 1646.
15. Linsley PS, Brady W, Urnes M, et al. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991; 174: 561.
16. Eagar TN, Karandikar NJ, Bluestone JA, et al. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eur J Immunol 2002; 32: 972.
17. Kirk, AD, Harlan DM. Challenges for the clinical application of transplant tolerance strategies. Curr Opin Organ Transplant 2000; 5: 108.
18. Waldmann H, Cobbold SP, Fairchild P, et al. Therapeutic aspects of tolerance. Curr Opin Pharmacol 2001; 1: 392.
19. Cho YW. Expanded criteria donors. Clin Transpl 1998; 421.
20. Pascher A, Reutzel-Selke A, Jurisch A, et al. Alterations of the immune response with increasing recipient age are associated with reduced long-term organ graft function of rat kidney allografts. Transplantation 2003; 76: 1560.
21. Reutzel-Selke A, Jurisch A, Denecke C, et al. Donor age intensifies the early immune response after transplantation. Kidney Int 2007; 71: 629.
22. Weiss S, Kotsch K, Francuski M, et al. Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 2007; 7: 1584.
23. Pascher A, Proesch S, Pratschke J, et al. Rat cytomegalovirus infection interferes with anti-CD4 mAb-(RIB 5/2) mediated tolerance and induces chronic allograft damage. Am J Transplant 2006; 6: 2035.
24. Martins PNA, Reutzel-Selke A, Pratschke J, et al. Donor and recipient age prevent tolerance induction. Am J Transplant 2006, 6(suppl): 895.
25. Nickel P, Presber F, Bold G, et al. Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients. Transplantation 2004; 78: 1640.
26. Kingsley CI, Nadig SN, Wood KJ. Transplantation tolerance: Lessons from experimental rodent models. Transpl Int 2007; 20: 828.
27. Bagley J, Tian C, Iacomini J. New approaches to the prevention of organ allograft rejection and tolerance induction. Transplantation 2007; 84(suppl): S38.
28. Salahudeen AK, Haider N, May W. Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney Int 2004; 65: 713.
29. Gajanayake T, Sawitzki B, Matozan K, et al. Dextran sulfate facilitates anti-CD4 mAb-induced long-term rat cardiac allograft survival after prolonged cold ischemia. Am J Transplant 2008; 8: 1151.
30. Reutzel-Selke A, Zschockelt T, Denecke C, et al. Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/ reperfusion injury and long-term graft function in renal allografts from older donors. Transplantation 2003; 75: 1786.
31. Yokota N, Daniels F, Crosson J, et al. Protective effect of T cell depletion in murine renal ischaemia-reperfusion injury. Transplantation 2002; 74: 759.
32. Torras J, Herrero-Fresneda I, Lloberas N, et al. Promising effects of ischemic preconditioning in renal transplantation. Kidney Int 2002; 61: 2218.
33. Herrero I, Torras J, Riera M, et al. Prevention of cold ischemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation. Nephrol Dial Transplant 1999; 14: 872.
34. Herrero-Fresneda I, Torras J, Vidal A, et al. Reduction of postischemic immune inflammatory response: An effective strategy for attenuating chronic allograft nephropathy. Transplantation 2005; 79: 165.
35. Rabb H, Daniels F, O'Donnell M, et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice.Am J Physiol 2000; 279: F525.
36. Burne MJ, Daniels F, El Ghandour A, et al. Identification of the CD4(-) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001; 108: 1283.
37. Savransky V, Molls RR, Burne-Taney M, et al. Role of the T-cell receptor in kidney ischemia-reperfusion injury. Kidney Int 2006; 69: 233.
38. Hochegger K, Schätz T, Eller P, et al. Role of alpha/beta and gamma/ delta T cells in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2007; 293: F741.
39. Daemen MA, de Vries B, van't Veer C, et al. Apoptosis and chemokine induction after renal ischemia-reperfusion. Transplantation 2001; 71: 1007.
40. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392: 86.
41. Rovere P, Vallinoto C, Bondanza A, et al. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol 1998; 161: 4467.
42. Heath WR, Kurts C, Miller JF, et al. Cross-tolerance: A pathway for inducing tolerance to peripheral tissue antigens. J Exp Med 1998; 187: 1549.
43. Burne-Taney MJ, Liu M, Baldwin WM, et al. Decreased capacity of immune cells to cause tissue injury mediates kidney ischemic preconditioning. J Immunol 2006; 176: 7015.
44. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007; 7: 610.
45. Min WP, Zhou D, Ichim TE, et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol 2003; 170: 1304.
46. Zhang X, Li M, Lian D, et al. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection. Clin Immunol 2008; 127: 313.
47. Otto C, Ohrlein E, Meyer D, et al. Detection of dendritic cells with down-regulated CD80/CD86, but normal MHC class II expression after rat liver transplantation. Transplant Proc 2001; 33: 442.
48. Ichikawa N, Demetris AJ, Starzl TE, et al. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: With particular reference to chronic rejection. Liver Transpl 2000; 6: 686.
49. Okuda T, Ishikawa T, Azhipa O, et al. Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: With particular emphasis on donor major histocompatibility complex class II- cells. Transplantation 2002; 74: 103.
50. Golshayan D, Buhler L, Lechler RI, et al. From current immunosuppressive strategies to clinical tolerance of allografts. Transpl Int 2007; 20: 12.
51. Vadivel N, Trikudanathan S, Chandraker A. Transplant tolerance through costimulation blockade-Are we there yet? Front Biosci 2007; 12: 2935.